Evidence map›Paper›PMID 25805794›Full record

ArticleEuropean journal of public health2015

Adolescents' medicine use for headache: secular trends in 20 countries from 1986 to 2010.

Bjørn E Holstein, Anette Andersen, Anastasios Fotiou, Inese Gobina, Emmanuelle Godeau, Ebba Holme Hansen, Ron Iannotti, Kate Levin, Saoirse Nic Gabhainn, Ulrike Ravens-Sieberer and 2 more

Abstract read
In one paragraph

Article in European journal of public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bjørn E Holstein1 University of Southern Denmark, National Institute of Public Health, Copenhagen, Denmark bho@niph.dk.
Anette Andersen1 University of Southern Denmark, National Institute of Public Health, Copenhagen, Denmark.
Anastasios Fotiou2 University Mental Health Research Institute, Athens, Greece.
Inese Gobina3 Department of Public Health and Epidemiology, Riga Stradins University, Riga, Latvia.
Emmanuelle Godeau4 French Institute of Health and Medical Research, Paris, France.
Ebba Holme Hansen5 Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
Ron Iannotti6 Eunice Kennedy Shriver National Institute of Child Health and Human Development, Prevention Research Branch, Bethesda MD, USA.
Kate Levin7 School of Medicine, Medical & Biological Sciences, University of St Andrews, St Andrews, Scotland.
Saoirse Nic Gabhainn8 Health Promotion Research Centre, School of Health Sciences, National University of Ireland, Galway, Ireland.
Ulrike Ravens-Sieberer9 Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Raili Välimaa10 Department of Health Sciences, University of Jyväskylä, Jyväskylän Yliopisto, Finland.
Medicine Use Writing Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study reports secular trends in medicine use for headache among adolescents in 20 countries from 1986 to 2010.

methodsThe international Health Behaviour in School-aged Children (HBSC) survey includes self-reported data about medicine use for headaches among nationally representative samples of 11-, 13- and 15-year-olds. We included 20 countries with data from at least three data collection waves, with a total of 380 129 participants.

resultsThe prevalence of medicine use for headaches varied from 16.5% among Hungarian boys in 1994 to 62.9% among girls in Wales in 1998. The prevalence was higher among girls than boys in every country and data collection year. The prevalence of medicine use for headaches increased in 12 of 20 countries, most notably in the Czech Republic, Poland, Russia, Sweden and Wales.

conclusionThe prevalence of medicine use for headaches among adolescents is high and increasing in many countries. As some medicines are toxic this may constitute a public health problem.

Indexed as

Adolescent BehaviorAdolescentAnalgesicsChildEuropeFemaleHeadacheHealth SurveysHumansMaleNorth AmericaSex FactorsAnalgesics

Identifiers

PMID25805794
PMCPMC4408544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.